US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 17.150
  • -0.100-0.58%
Close May 3 16:00 ET
  • 17.150
  • 0.0000.00%
Post 16:01 ET
752.42MMarket Cap-35000P/E (TTM)

Y-mAbs Therapeutics Key Stats

Y-mAbs Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 7, 2024

Revenue(YoY)

22.22M

+9.72%
EPS(YoY)

-0.15

-1.67%

Strong Buy

Apr 30, 2024

Y-mAbs Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 23.960M--
May 7, 20242024/Q1-- / 22.220M--
Feb 29, 20242023/Q423.363M / 20.954M--
Nov 13, 20232023/Q320.454M / 20.929M--
Aug 10, 20232023/Q220.751M / 20.347M--
May 8, 20232023/Q120.251M / 15.554M--
Mar 30, 20232022/Q431.447M / 20.349M--
Nov 7, 20222022/Q312.537M / 12.008M--
Aug 8, 20222022/Q210.797M / 11.216M--
May 9, 20222022/Q110.486M / 10.901M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 23.960M--
May 7, 20242024/Q1-- / 22.220M--
Feb 29, 20242023/Q423.363M / 20.954M--
Nov 13, 20232023/Q320.454M / 20.929M--
Aug 10, 20232023/Q220.751M / 20.347M--
May 8, 20232023/Q120.251M / 15.554M--
Mar 30, 20232022/Q431.447M / 20.349M--
Nov 7, 20222022/Q312.537M / 12.008M--
Aug 8, 20222022/Q210.797M / 11.216M--
May 9, 20222022/Q110.486M / 10.901M--

Unlock Free Earnings Estimates

Y-mAbs Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg